Furthermore, a significantly higher prevalence of TP53 mutations in EO-CRC can lead to the loss of p53 tumor suppression and pro-tumorigenic gain-of-function effects which can accelerate colonic cell proliferation, angiogenesis, and metastasis [20,21]. This evidence concerns the gene TP53 and neoplasm.